Automating your primary vial pre-processing steps
The cobas p 480 Instrument is a simple and flexible stand-alone solution that eliminates complications associated with manual sample handling. Automate labour-intensive interactions - allows technicians to focus on more sophisticated activities Minimise opportunity for sample contamination - increases sample reproducibility and process reliability.
Removes caps from primary tubes for testing on the cobas® 4800, 6800 or 8800 Systems
Up to 1,536 samples in an 8-hour shift
Recaps sample vials with new caps to avoid contamination
Up to 1,536 samples in an 8-hour shift
Aliquots configurable volumes from PreservCyt®, SurePath™ and cobas® PCR Cell Collection Media primary vials into barcode matched secondary tubes.
Up to 672 samples in an 8-hour shift
Addition of cobas® Sample Prep Buffer and incubation of specimens collected in SurePath™medium to reverse cross-linking and free nucleic acids for testing1,*
Up to 1,536 samples in an 8-hour shift
The cobas p 480 Instrument uses a combination of physical, software, and process-based controls to ensure confidence in sample and result integrity.
Reduces aerosol production during tip ejection
Real-time monitoring of aspiration and dispensing steps
Continually monitors pipetting channel pressure and adjusts in real time
Achieve process reliability and full data tracking with the intuitive software and process controls of the cobas p 480 Instrument. Featuring easy-to-use software and a simple and intuitive interface, you can keep your pre-analytic processes under complete control.
The cobas p 480 Instrument improves laboratory efficiency by allowing valuable technician time to be used more productively, eliminating repetitive, manual sample handling, improving workflow and reducing risk of contamination, human error and workplace injury.
Access package inserts through your country’s Roche Diagnostics Website.
* Automation of the SurePath™ pre-treatment procedure with the cobas p 480 Instrument has not been reviewed by FDA and is not approved in the US.
References
